









Mercado
/
Acciones
/
nasdaq-rvty
/

Revvity Inc

RVTY

101.590USD

+2.070+2.08%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

11.52BCap. mercado

49.11P/E TTM



Revvity Inc

101.590

+2.070+2.08%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Revvity Inc Compañía

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Información de Revvity Inc



Símbolo de cotizaciónRVTY

Nombre de la empresaRevvity Inc

Fecha de salida a bolsaAug 12, 2101

Director ejecutivoSingh (Prahlad R)

Número de empleados11000

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 12

Dirección77 4Th Avenue

CiudadWALTHAM

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal02451

Teléfono17816636900

Sitio Webhttps://www.revvity.com/

Símbolo de cotizaciónRVTY

Fecha de salida a bolsaAug 12, 2101

Director ejecutivoSingh (Prahlad R)

Ejecutivos de Revvity Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

96.84K

-9420.00%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+2840.00%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+4289.00%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+2412.00%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

22.80K

-559.00%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+5454.00%

Ms. Pascale Witz

Independent Director

13.71K

+2412.00%

Mr. Tajinder S. Vohra

Senior Vice President - Global Operations

10.44K

Mr. Michael A. Klobuchar

Independent Director

5.09K

+2412.00%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

5.09K

+2412.00%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Prahlad R. Singh, Ph.D.

President, Chief Executive Officer, Director

96.84K

-9420.00%

Mr. Alexandros P. (Alexis) Michas

Independent Non-Executive Chairman of the Board

45.44K

+2840.00%

Mr. Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

37.69K

+4289.00%

Dr. Peter Barrett, Ph.D.

Independent Director

26.01K

+2412.00%

Mr. Maxwell Krakowiak

Chief Financial Officer, Senior Vice President

22.80K

-559.00%

Ms. Miriame Victor

Chief Commercial Officer, Senior Vice President

14.29K

+5454.00%

Desglose de ingresos

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

La empresa aún no ha revelado los datos relevantes.

Por regiónUSD

Nombre

Ganancia

Proporción

Americas

509.67M

0.00%

Europe

391.67M

0.00%

Asia

189.28M

0.00%

Por negocio

Por región

La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: vie., 16 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

T. Rowe Price Investment Management, Inc.

19.85%

The Vanguard Group, Inc.

11.58%

EdgePoint Investment Group Inc.

7.56%

T. Rowe Price Associates, Inc.

7.05%

Janus Henderson Investors

6.73%

Otro

47.23%

Accionistas

Proporción

T. Rowe Price Investment Management, Inc.

19.85%

The Vanguard Group, Inc.

11.58%

EdgePoint Investment Group Inc.

7.56%

T. Rowe Price Associates, Inc.

7.05%

Janus Henderson Investors

6.73%

Otro

47.23%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

69.02%

Investment Advisor/Hedge Fund

26.41%

Hedge Fund

2.80%

Pension Fund

1.70%

Research Firm

1.69%

Sovereign Wealth Fund

1.18%

Bank and Trust

0.74%

Individual Investor

0.30%

Family Office

0.05%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1172

117.68M

103.80%

-9.10M

2025Q3

1177

117.06M

100.85%

-8.83M

2025Q2

1199

113.79M

98.03%

-7.04M

2025Q1

1255

117.73M

99.83%

-3.82M

2024Q4

1277

114.54M

95.28%

-3.97M

2024Q3

1253

112.35M

91.11%

-5.77M

2024Q2

1249

112.44M

91.13%

-1.63M

2024Q1

1287

107.57M

87.09%

-8.24M

2023Q4

1315

109.29M

88.55%

-2.41M

2023Q3

1347

106.10M

85.47%

-6.10M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

T. Rowe Price Investment Management, Inc.

22.50M

19.85%

-140.67K

-0.62%

Sep 30, 2025

The Vanguard Group, Inc.

13.47M

11.88%

-564.06K

-4.02%

Sep 30, 2025

EdgePoint Investment Group Inc.

8.57M

7.56%

+1.78M

+26.28%

Sep 30, 2025

T. Rowe Price Associates, Inc.

8.00M

7.05%

+196.30K

+2.52%

Sep 30, 2025

Janus Henderson Investors

7.63M

6.73%

+405.54K

+5.62%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

6.04M

5.33%

+229.56K

+3.95%

Sep 30, 2025

State Street Investment Management (US)

4.95M

4.36%

-71.58K

-1.43%

Sep 30, 2025

Geode Capital Management, L.L.C.

2.96M

2.61%

-16.67K

-0.56%

Sep 30, 2025

Invesco Capital Management LLC

2.26M

1.99%

+317.90K

+16.41%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

2.13M

1.88%

+596.44K

+38.99%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

First Trust Indxx Medical Devices ETF

2.12%

Invesco S&P 500 Equal Weight Health Care ETF

1.85%

T Rowe Price Capital Appreciation Equity ETF

1.36%

Simplify Health Care ETF

1.29%

ROBO Global Healthcare Technology & Innovation ETF

1.16%

First Trust Health Care Alphadex Fund

0.93%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.84%

VanEck Morningstar SMID Moat ETF

0.64%

Neuberger Berman Small-Mid Cap ETF

0.56%

NYLI Candriam US Mid Cap Equity ETF

0.5%

First Trust Indxx Medical Devices ETF

Proporción2.12%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.85%

T Rowe Price Capital Appreciation Equity ETF

Proporción1.36%

Simplify Health Care ETF

Proporción1.29%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.16%

First Trust Health Care Alphadex Fund

Proporción0.93%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

Proporción0.84%

VanEck Morningstar SMID Moat ETF

Proporción0.64%

Neuberger Berman Small-Mid Cap ETF

Proporción0.56%

NYLI Candriam US Mid Cap Equity ETF

Proporción0.5%

Dividendos



Un total de 137.14M USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Oct 23, 2025

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026

Jan 16, 2026

Feb 06, 2026

Jan 16, 2026

Jul 24, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025

Oct 17, 2025

Nov 07, 2025

Oct 17, 2025

Apr 24, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025

Jul 18, 2025

Aug 08, 2025

Jul 18, 2025

Jan 23, 2025

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025

Apr 18, 2025

May 09, 2025

Apr 17, 2025

Oct 24, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025

Jan 17, 2025

Feb 07, 2025

Jan 17, 2025

Jul 25, 2024

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024

Oct 18, 2024

Nov 08, 2024

Oct 18, 2024

Apr 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024

Jul 19, 2024

Aug 09, 2024

Jul 19, 2024

Jan 25, 2024

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024

Apr 19, 2024

May 10, 2024

Apr 18, 2024

Oct 26, 2023

RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024

Jan 19, 2024

Feb 09, 2024

Jan 18, 2024

Jul 21, 2023

RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 10, 2023

Oct 19, 2023

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

